Pharmacotherapeutic strategies for treating hypertension in patients with obesity.


INTRODUCTION Hypertension and obesity are important health challenges that independently increase cardiovascular morbidity and mortality. There is a lack of randomized controlled trials to clearly inform on preferred drug choices to be adopted in clinical practice for the treatment of obesity-related hypertension (OHT). Adequate differentiation of drug… (More)
DOI: 10.1080/14656566.2018.1458092


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.